uniQure Switzerland GmbH
Biotechnology · Basel, Basel-Stadt
uniQure Switzerland GmbH is a Swiss biotechnology company based in Basel, Canton of Basel-Stadt, listed in the Swiss commercial register since 2020 (UID CHE-486.007.268).
Board members & signatories
- Richard Porter — Vorsitzender der Geschäftsführung
- Christian Klemt — Geschäftsführer
- Jeannette Potts — Geschäftsführer
Registered purpose
Die Gesellschaft bezweckt Erbringung von Dienstleistung im Bereich der Forschung und Entwicklung von pharmazeutischen Produkten und Dienstleistungen für Dritte, einschliesslich aller allgemeinen, administrativen, Neben- und Nebenleistungen zur Unterstützung dieses Zwecks. Die Gesellschaft kann alle kommerziellen, vertraglichen und finanziellen Geschäfte eingehen, die geeignet sind, den Zweck der G…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What uniQure Switzerland does
OFFERING
uniQure focuses on gene therapy, with a pipeline that includes treatments for Huntington’s disease, Temporal Lobe Epilepsy (TLE), Fabry disease, ALS (SOD1), and Hemophilia B. The company emphasizes the development of innovative therapies that aim to transform patient care.
Unlock the full analysis →Similar companies
- Qurelis Pharma GmbH — Pharmaceuticals · Pfäffikon SZ
- Quercis Pharma AG — Pharmaceuticals · Zug
- Orchard Therapeutics (Switzerland) GmbH — Life Sciences Services (CRO / Consulting) · Zug
- HiQScreen Sàrl — Contract Development & Manufacturing (CDMO) · Vésenaz
- PPM Services SA — Contract Development & Manufacturing (CDMO) · Morbio Inferiore
- PAREXEL International (CH) AG — Contract Development & Manufacturing (CDMO) · Basel
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime